INmune Bio Establishes Global Commercialization Framework for Ebstrocel™ Through Strategic Agreement with Uniphar

SpectaCell launches with €6 million to transform drug development and bring better immune therapies to patients faster

Forbion raises €2.3 billion across two new funds

RougeTx Launches with $58 Million Series A Financing to Advance First-in-Class Treatment for Hereditary Hemorrhagic Telangiectasia

Amplio Pharma reports positive early clinical results for NovoBioJect

Zymofix to build flagship microbial manufacturing plant as it takes solid-state fermentation to industrial scale

Amsterdam UMC Ventures Holding investeert €4 miljoen om nieuwe toepassingen van bestaande medicijnen naar de patiënt te brengen

Phosphoenix Secures €1.3 Million Financing to Advance Visual Neuroprosthetic Technology

Remynd secures €3.5 million investment from the Alzheimer's Drug Discovery Foundation to take its first-in-class septin modulator into Alzheimer's patients